Neoadjuvant Chemotherapy With a Combination of Pegylated Liposomal Doxorubicin (Caelyx®) and Paclitaxel in Breast Cancer
Clinical trial NCT03221881 · COMPLETED
Trial details
- NCT number
- NCT03221881
- Sponsor
- Hebei Medical University Fourth Hospital
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-01
- Primary completion
- 2017-04-01
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.